We use privacy-respecting analytics to understand how the platform is
used. No third-party tracking, no cross-site profiling, no sale of
data. Your inquiry data is held within EU jurisdiction.
CoreFlux is a multi-modal sensing platform capturing continuous physiology from
across the male body — reproductive, cardiovascular, neurological,
musculoskeletal — and translating it through CoreFlux AI into clinical-grade
insight.
Helsinki University Hospital (clinical pathway in progress)
The problem
The most important signals in men's health are the ones nobody is capturing.
Wrist wearables read a single pulse point and call it health. But the signals that
determine how long men live, and how well, come from across the body — and most of
them are invisible to consumer technology today.
50–60%
decline in global sperm counts over the past 50 years
Levine et al., 2022 · Hum. Reprod. Update
4×
higher male mortality from cardiovascular disease before age 65
WHO Global Health Estimates, 2024
3×
higher rate of suicide in men versus women
OECD Health at a Glance, 2023
Men are under-measured. CoreFlux exists to correct that.
Why now
Three forces converged. None existed five years ago.
CoreFlux is not a thesis waiting for a market. The technology, the science,
and the cultural permission to measure male physiology continuously have all
arrived inside the same window — for the first time.
01
Sensor science matured
Flexible PCB tail sensors — the foundation of wash-durable apparel
electronics — cleared laboratory validation only in the last 24 months.
Embedding clinical-grade signal into garment pattern is now an
engineering problem, not a research one.
02
Personalized AI became viable
Adaptive baseline modeling makes whole-body physiology interpretable
per individual, not per population. Population averages hide the
deviations that matter — and until recently, on-device personal baseline
learning at this resolution was a research artifact.
03
Men's health is a category now
The FemTech expansion of 2015–2020 proved the playbook: serious,
continuous physiological measurement for an under-measured population
builds a durable category. Men ask for this data today. Five years
ago they didn't.
How it works
One sensing ecosystem. Four body zones. One intelligence layer.
CoreFlux is not a device. It is a platform — a single Pod that moves between four
garments, each engineered to capture the physiology of a specific body zone. The
result is the first continuous, whole-body data stream built for men.
SCHEMATIC · SYS-001REV. 2026.02
CoreFlux Ecosystem · signal flow
01 · MIND
Headband
Neurological · sleep
EEG-informed recovery, stress, and cognitive load metrics
with full sleep architecture.
02 · HEART
Shirt
Cardiovascular · respiratory
Continuous ECG-grade signal, breathing variability, and
upper-body posture load.
03 · SEED 360
Boxer Briefs
Reproductive · hormonal · pelvic
Dual Pods — front and back — give 360° coverage of the
male pelvis. Temperature, scrotal perfusion, and biomarker
indices no other wearable measures.
04 · ROOT
Insoles
Gait · musculoskeletal
Asymmetry, impact, peripheral vascular signals, and
full gait telemetry.
05 · REST
Sleep Dock
Sleep environment · charging
Bedside companion. Captures air quality, light, and
sound to sharpen sleep analysis — and charges the Pod
overnight.
Powered by a single CoreFlux Pod. Sleep environment
captured by REST. Interpreted by
CoreFlux AI.
Intelligence layer
CoreFlux AI
The adaptive intelligence layer. CoreFlux AI learns each user's physiological baseline
and surfaces deviations that matter — turning raw signal into
guidance a clinician would recognize.
Defensibility
What the wrist can't see.
Oura, Whoop, and Apple Watch optimized the periphery — pulse, motion,
oxygen at extremities. CoreFlux operates at a category they cannot reach
without rebuilding from the ground up.
A · ANATOMICAL ACCESS
Where wrist sensors physically can't read.
A ring or watch reads one point. CoreFlux's Pod moves between four garments
to capture signal across the chest, head, lower body, and feet — including
reproductive and hormonal markers no consumer wearable measures.
B · APPAREL AS A PLATFORM
Smart textile, finally solved.
Smart-textile attempts have failed on washability and electronics lifecycle.
CoreFlux decouples them: one durable Pod across many wash cycles, sensor
garments worn and replaced like any other clothing.
C · BUILT FOR MEN
A category nobody has built.
Reproductive, hormonal, gait, and lower-body signals — captured continuously,
in the form factor men already wear. No other consumer-grade platform
exists in this space.
They operate at the periphery. We measure from the source.
Validation
Engineered in partnership with the institutions that define
Nordic medtech.
CoreFlux is being co-developed with VTT, the Technical Research Centre of Finland,
using flexible PCB tail sensor technology validated at laboratory scale.
Manufacturing and productization are being scoped with Haltian, the team behind
Oura Ring. Clinical validation pathways have been established with Helsinki
University Hospital (HUS) through our VTT relationship.
A disciplined sequence of milestones: institutional validation first, then
productization, then clinical. Each gate de-risks the next.
Feb 2026
NDA signed with VTT. POC engagement initiated —
€24k, flexible PCB tail sensor.
2026 — Q1
NDA signed with Haltian. Concept phase scoped;
productization pathway defined.
2026 — Q1
Clinical validation channel established with HUS
via the VTT relationship.
In progress
Prototype sensor integration and first garment pattern (SEED 360).
Next
First-generation prototype delivery. Seed round close.
CoreFlux AI development sprint.
Who's building this
Built by operators who have done this before — at scale,
in industry, and across borders.
Mareus Suni
Co-founder
Two decades of international CFO and finance leadership across
industrial and technology companies. Finance systems, fundraising,
and operational execution.
Consumer retail background with direct experience in product, user,
and brand development. Co-leads product direction, clinical strategy
coordination, and Nordic partner relations across the VTT and Haltian
engagements.
We are raising a seed round to bring the first prototype to
validated trial.
Use of funds:
prototype production, VTT POC completion, Haltian concept-to-productization
transition, CoreFlux AI core development, and clinical validation preparation
with HUS.
In conversation with
Healthtech and hardware angel investors
In conversation with
Nordic and European seed funds
In conversation with
Strategic partners in men's health, reproductive medicine, and wearables
A deeper look at the sensor architecture, validation pathway, and clinical
strategy. Full technical brief in preparation — these are the sections that
will ship.
01
Hardware
Sensor architecture
CoreFlux is built around a single hardware primitive: a flexible PCB
tail sensor that can be embedded into a textile pattern without
compromising garment fit, drape, or wash durability.
Multi-modal integration. A single sensor lane carries thermal, optical, electrical, and motion channels — four modalities, one routing.
Snap-on Pod. Expensive electronics live in a magnetic Pod that detaches for charging and re-attaches across four garment types. Sensor garments are washable; the Pod is durable.
Anatomically anchored zones. Each garment is engineered to a specific body region — head, chest, lower body, feet — with sensor placement validated against anatomical landmarks rather than convenience.
The fundamental smart-textile problem is not sensors. It is washability and
electronics lifecycle. CoreFlux solves it by separating the two.
02
Software
Signal processing & CoreFlux AI
Raw signal is not the product. Interpretation is. CoreFlux AI translates
multi-zone physiology into a personal baseline a clinician
would recognize.
7-day calibration. The first week establishes an individual baseline across all measured signals — not a population average.
Deviation surfacing. The model flags meaningful departures from that baseline rather than dumping raw streams to the user.
Synthesis, not data quantity. CoreFlux AI's advantage comes from access to signals nobody else captures — not from a larger model. Whoever owns the source owns the interpretation layer.
A general health AI can be trained anywhere. A model trained on
continuous male physiology from four anatomical zones cannot.
03
Validation
Validation pathway
Three institutional partners, each gating the next stage —
de-risked sequentially, not in parallel.
STAGE 01
VTT
Engineering POC
In progress
Flexible PCB tail sensor validated at laboratory scale.
Engineering feasibility for embedding in a wash-durable
garment pattern.
STAGE 02
Haltian
Productization · DFM
Scoped
Concept-to-DFM scoped with the team behind Oura Ring.
Manufacturing pathway, supply chain, and tier-1 partner
discussions.
STAGE 03
HUS
Clinical pathway
Pathway established
Helsinki University Hospital validation channel established
through the VTT relationship. Validated trial capacity
in place.
04
Defensibility
Three-layer IP moat
Defensibility is not a single patent. It is a stack of structural
advantages that compound.
Hardware IP. Magnetic Pod-to-textile interface, anatomical sensor configurations, and integration of thermal sensing into flexible textile substrates. First patent application establishing priority is filed alongside the VTT POC output.
Software IP. The CoreFlux Fusion Model is held as trade secret first — the value compounds with proprietary signal access, not the algorithm itself.
Brand IP. CoreFlux is in active trademark filing across PRH (Finland) and EUIPO (Europe).
Anatomical access is its own moat: a wrist sensor cannot read scrotal
thermal load or pelvic-floor EMG, ever — by physics.
05
Privacy
Data & privacy posture
Continuous male physiology — reproductive signal especially — is among
the most sensitive data a person can generate. The architecture
reflects that.
EU-jurisdiction by default. CoreFlux Health Oy is a Finnish entity. User data is stored within EU jurisdiction; no cross-border transfer without explicit consent.
On-device baseline. Personal baseline learning runs locally on the Pod where viable. Cloud is used for cohort-level analytics and model updates, not raw signal storage.
GDPR by design. Right to access, port, and delete are first-class operations — not retrofits.
No third-party data sales. The business model is subscription, not data brokerage. This is a structural commitment, written into the product, not a marketing line.
06
Regulatory
Standards & regulatory pathway
CoreFlux ships in two regulatory phases: wellness positioning
first, medical certification second.
Phase 1 · Wellness. Initial product enters market under wellness positioning. No medical claims; clinical-grade signal exposed as physiological insight.
Phase 2 · CE Class IIa MDR. Clinical evaluation pathway initiated through HUS during the seed phase. Full certification is a Series A deliverable, not a seed promise.
ISO 13485 roadmap. Quality management system scoped with Haltian during the productization phase.
FDA pathway. US market entry follows EU MDR — sequence locked, not parallel.
Regulatory honesty: a startup claiming “FDA-cleared” in 24 months
with hardware not yet manufactured is a startup to be skeptical of.
We sequence the work.
Activity log
Recent updates
The technical platform evolves continuously. Each entry below maps
to a versioned milestone in the engineering build.
v0.3May 2026
ENGINEERING
Productization phase initiated with Haltian. DFM scoping engagement formalized; manufacturing pathway under active design.
Foundational partnerships formalized — NDA agreements with VTT and Haltian; clinical channel established through HUS.
v0.0Jan 2026
FOUNDATION
CoreFlux Health Oy incorporated. Co-founders formalized roles, capital structure established.
Last reviewed — May 2026. Updates published quarterly.
SYS
TX 250 HzBASELINE T+24hDEVIATION σ 0.04SYNC OKNODES 4/4POD v0.3 — DFM scopeQMS ISO 13485 mappingREG CE IIa pathwayDATA EU jurisdictionCRYPTO at rest + in transitTX 250 HzBASELINE T+24hDEVIATION σ 0.04SYNC OKNODES 4/4POD v0.3 — DFM scopeQMS ISO 13485 mappingREG CE IIa pathwayDATA EU jurisdictionCRYPTO at rest + in transit
Two operators with twenty years of building scaled, regulated
businesses — finally turning that operational rigor toward a problem
the wearable industry has missed.
01
Founders
Mareus Suni
Co-founder · Finance & Operations
Two decades of international CFO and finance leadership across
industrial and technology companies. Mareus owns finance systems,
fundraising, investor relations, and operational execution at CoreFlux.
Track record includes full-cycle financial leadership through
international growth phases, M&A, and capital structure work
in regulated industries.
2000sIndustrial & technology CFO roles, international scaling
2010sNaava — turnaround and restructuring leadership
2018–2022Revieve — US operations & finance build-out
Consumer retail background with direct experience in product,
user, and brand development. Mana co-leads product direction,
clinical strategy, and the user-facing layer of the platform.
Drives the editorial voice and the cultural positioning of
CoreFlux — the part of the work that translates clinical-grade
signal into something men will actually wear.
“Technology only matters if people actually wear it. My job is to make sure they do.”
02
How we operate
Four principles. Each is a constraint, not a slogan — they
determine what gets shipped and what gets cut.
P.01
Engineering rigor before commercial speed.
We pursue clinical-grade signal first. Market velocity follows.
A platform built on shaky physiology compounds risk; one built
on validated signal compounds trust.
P.02
Clinical-grade evidence in every release.
Even pre-MDR. The product ships in wellness positioning, but
every signal we surface is validated against clinical reference
ranges. We will not ship insight we cannot defend in front of
a clinician.
P.03
European data sovereignty by architecture.
Not a policy line — an architectural decision. EU jurisdiction,
on-device baseline learning, no third-party data sales. Built
into the system before any commercial pressure can erode it.
P.04
Lean by design — capital builds the core.
The seed round funds technology, not overhead. VTT and Haltian
partnerships replace the in-house engineering team this stage
would normally require. Every euro is accountable to the core.
03
Institutional partners
Three named partners across engineering, productization, and clinical
validation. Not LOIs — active engagements.
VTT
Engineering POC
Technical Research Centre of Finland. Validates the flexible PCB
tail sensor at laboratory scale and grants engineering feasibility
for textile embedding.
Haltian
Productization · DFM
The team behind Oura Ring. Concept-to-DFM scoping, tier-1
manufacturing pathway, and ISO 13485 quality system scoping.
HUS
Clinical channel
Helsinki University Hospital. Validation pathway and trial
capacity for CE Class IIa MDR clinical evaluation, established
through the VTT relationship.
04
Advisory bench
In formation. We name advisors only with explicit permission and
a documented engagement — no decorative logos. Open seats below
are concrete role specs, not vague gestures.
Clinical / Urology
Confirmed advisor with men's reproductive health expertise. Public disclosure on engagement formalization.
Confirmed · pending disclosure
Wearable hardware
Smart-textile or flexible electronics lead with shipped consumer hardware in the wearables category. Particularly interested in operators from Oura, Whoop, Withings.
Open · in conversation
Regulatory · CE MDR
Class IIa MDR pathway specialist with documented EU notified body relationships. Ideal candidate has navigated wellness-to-medical reclassification before.
Open · in conversation
Go-to-market · Men's health
Operator who has built a men's-health consumer brand from zero to category awareness. Direct-to-community channels and athlete partnerships preferred over paid acquisition.
Open
05
We are hiring
Post-seed, the first three roles are Hardware Lead,
Embedded / Signal Processing, and
Clinical Affairs Lead. We hire the founding engineering
team only after seed close — not before.
If any of those is your work, write to us. We respond to every signal.
You followed a link to a route we have not built. The address bar may
contain a typo, or the page may have been retired. Either way — the
platform is one step back.
For journalists, analysts, and editors covering men's health,
wearable technology, and Nordic medtech. Materials below are
pre-cleared for use with attribution.
Response within one business day · EU jurisdiction
01
Company at a glance
A factual one-pager. Use any line below without prior approval; please attribute to CoreFlux Health Oy.
Entity
CoreFlux Health Oy
Registered
Espoo, Finland
Founded
January 2026
Stage
Seed
Founders
Mareus Suni · Mana Suni
Focus
Multi-modal sensing platform for male physiology
Partners
VTT · Haltian · HUS
Tagline
“We measure from the source.”
02
Approved positioning lines
Short paragraphs cleared for reuse in articles, profiles, and reviews. Please quote verbatim or paraphrase without altering substance.
“
CoreFlux is a multi-modal sensing platform capturing continuous physiology from across the male body — reproductive, cardiovascular, neurological, musculoskeletal — translated by CoreFlux AI into clinical-grade insight.
Platform positioning · short form
“
While wrist wearables read a single pulse point, CoreFlux operates at the body zones where signal originates: chest, head, lower body, and feet. The first continuous, whole-body data stream built for men.
Differentiation · short form
“
CoreFlux is being co-developed with VTT, the Technical Research Centre of Finland, and being scoped for productization with Haltian — the team behind Oura Ring. Clinical validation pathways are established through Helsinki University Hospital.
Partnerships · short form
03
Brand & assets
Logos, founder photos, and OG card. For broadcast-quality assets, contact press@coreflux.health.
Continuous male physiology is among the most sensitive data a person
generates. The architecture reflects that. Below is what we collect,
what we don't, and how it is held.
01
Website data
What this website collects
This site is intentionally lean. We collect only the
data you explicitly provide through the contact form
— name, email, company, inquiry type, and your message.
No third-party trackers. No Google Analytics, no Meta Pixel, no LinkedIn tag, no advertising cookies.
No cross-site profiling. Browsing this site does not feed any external profile.
Privacy-respecting analytics, when added. If we add analytics, it will be a cookieless solution (Plausible or Fathom). You will see a banner and can opt out before any signal is captured.
This page exists because we built the privacy posture before we
built the analytics. Not the other way around.
02
Storage & jurisdiction
Where your data lives
All inquiry data is held within European Union
jurisdiction. No cross-border transfer occurs without
explicit consent.
Contact form submissions are processed via Web3Forms (EU-based processor) and forwarded to contact@coreflux.health.
Email correspondence is hosted within EU jurisdiction with end-to-end TLS in transit.
No data sales. Third-party sharing is structurally not part of our business model — not a policy decision that could be reversed under commercial pressure.
03
Your rights (GDPR)
Rights, retention, and how to act on them
Under GDPR, you have the right to access, port, correct, and
delete your personal data. We honor these requests within
30 days.
Right to access. Request a copy of what we hold about you.
Right to deletion. Request removal from our records.
Right to portability. Receive your data in a structured, machine-readable format.
Retention. Inquiry data is retained for up to 36 months from last interaction unless you request earlier deletion.
To exercise any right, email contact@coreflux.health with subject “GDPR request · [your name].” Response within one business day.
04
Product data (future)
Product privacy commitments
The CoreFlux platform is in pre-product stage. When it ships,
the architecture will follow the principles below.
On-device baseline learning. Personal baseline runs on the Pod where viable. Cloud is used for cohort analytics and model updates, not raw signal storage.
User-owned data model. Export, delete, and revoke access are first-class operations — not retrofits.
EU jurisdiction by default. Data residency is an architectural decision, not a policy line.
No advertising surface. Personal physiology data is not used to target advertising — not for CoreFlux, not for partners, not ever.
05
Contact
Data controller
CoreFlux Health Oy, registered in Espoo,
Finland. For any privacy or data protection question:
